CoChat
Sign Up
Cited by 433

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Identification of Markers that Distinguish Monocyte-Derived Fibrocytes from Monocytes, Macrophages, and Fibroblasts

Pilling, Darrell, Fan, Ted, Huang, Donna, Kaul, Bhavika, Gomer, Richard H.·2009·PLoS ONE
DOI 10.1371/journal.pone.0007475PMC PMC2759556
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0007475

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Expression of markers on monocytes, macrophages, fibrocytes, and fibroblasts. Combined data on the expression of markers on the cells analyzed.
Figure 1 Expression of markers on monocytes, macrophages, fibrocytes, and fibroblasts. Combined data on the expression of markers on the cells analyzed.CC BY · PubMed Central
Figure 2 Expression of CD13, CD14, and CD45 isoforms on fibrocytes. PBMC were cultured in SFM at 5×105 cells/ml in 8-well glass slides for 7 days. Cells were then air-dried, fixed, and stained with antibodies. A) CD13, B) CD14, C) CD45RA, D) CD45RB, E) CD45RO, F) Irrelevant mouse IgG2a control. Cells were then counterstained with hematoxylin to identify nuclei. Positive staining was identified by red staining, with nuclei counterstained blue. Solid arrow points to a fibrocyte, open arrow points to a macrophage, and asterisk indicates a cluster of lymphocytes. Photomicrographs are representative results from at least four different donors. Bar is 50 µm.
Figure 2 Expression of CD13, CD14, and CD45 isoforms on fibrocytes. PBMC were cultured in SFM at 5×105 cells/ml in 8-well glass slides for 7 days. Cells were then air-dried, fixed, and stained with antibodies. A) CD13, B) CD14, C) CD45RA, D) CD45RB, E) CD45RO, F) Irrelevant mouse IgG2a control. Cells were then counterstained with hematoxylin to identify nuclei. Positive staining was identified by red staining, with nuclei counterstained blue. Solid arrow points to a fibrocyte, open arrow points to a macrophage, and asterisk indicates a cluster of lymphocytes. Photomicrographs are representative results from at least four different donors. Bar is 50 µm.CC BY · PubMed Central
Figure 3 Expression of markers on fibrocytes, fibroblasts, and endothelial cells. PBMC were cultured as described in Figure 1. Normal human dermal fibroblasts and HUVECs were cultured for 2 days in 8-well glass slides. Cells were then air-dried, fixed, and stained with antibodies against A–C) CD43, D–F) CD44, G–I) CD45, J–L) LSP-1, and M–O) CD29. Cells were then counterstained with hematoxylin to identify nuclei. Bar is 50 µm.
Figure 3 Expression of markers on fibrocytes, fibroblasts, and endothelial cells. PBMC were cultured as described in Figure 1. Normal human dermal fibroblasts and HUVECs were cultured for 2 days in 8-well glass slides. Cells were then air-dried, fixed, and stained with antibodies against A–C) CD43, D–F) CD44, G–I) CD45, J–L) LSP-1, and M–O) CD29. Cells were then counterstained with hematoxylin to identify nuclei. Bar is 50 µm.CC BY · PubMed Central
Figure 4 Comparison of markers on PBMC ex-vivo and fibrocytes. PBMC were cultured in SFM at 5×105 cells/ml in 8-well glass slides for 1 hour (ex vivo) or 7 days. Cells were then air-dried, fixed, and stained with antibodies. A and B) CD35, C and D) CD93, E and F) S100A8/9, G and H) 25F9, and I and J) PM-2K. Cells were then counterstained with hematoxylin to identify nuclei. Bar is 50 µm.
Figure 4 Comparison of markers on PBMC ex-vivo and fibrocytes. PBMC were cultured in SFM at 5×105 cells/ml in 8-well glass slides for 1 hour (ex vivo) or 7 days. Cells were then air-dried, fixed, and stained with antibodies. A and B) CD35, C and D) CD93, E and F) S100A8/9, G and H) 25F9, and I and J) PM-2K. Cells were then counterstained with hematoxylin to identify nuclei. Bar is 50 µm.CC BY · PubMed Central
Figure 5 Detection of surface markers on monocytes by flow cytometry. PBMC were stained with mouse monoclonal antibodies and then analyzed by flow cytometry. Monocytes were identified by their forward and side scatter characteristics and the expression of CD14. Histograms show fluorescence intensity of isotype control antibody (black line) compared to the indicated marker (red line) on monocytes. Flow cytometry plots are representative results from six separate donors. Graph shows the percent positive monocytes expressed as the mean±SEM (n = 6 separate donors).
Figure 5 Detection of surface markers on monocytes by flow cytometry. PBMC were stained with mouse monoclonal antibodies and then analyzed by flow cytometry. Monocytes were identified by their forward and side scatter characteristics and the expression of CD14. Histograms show fluorescence intensity of isotype control antibody (black line) compared to the indicated marker (red line) on monocytes. Flow cytometry plots are representative results from six separate donors. Graph shows the percent positive monocytes expressed as the mean±SEM (n = 6 separate donors).CC BY · PubMed Central
Figure 6 Expression of monocyte/macrophage markers on fibrocytes. PBMC were cultured as described in Figure 1. Cells were then air-dried, fixed, and stained with antibodies against A) CD18, B) CD68, C) CD163, D) CD206, E) CD209, and F) mouse IgG1 control. Cells were then counterstained with hematoxylin to identify nuclei. Bar is 50 µm.
Figure 6 Expression of monocyte/macrophage markers on fibrocytes. PBMC were cultured as described in Figure 1. Cells were then air-dried, fixed, and stained with antibodies against A) CD18, B) CD68, C) CD163, D) CD206, E) CD209, and F) mouse IgG1 control. Cells were then counterstained with hematoxylin to identify nuclei. Bar is 50 µm.CC BY · PubMed Central
Figure 7 Comparison of fibroblast markers on fibrocytes, fibroblasts, and HUVECs. PBMC were cultured as described in Figure 1. Normal human dermal fibroblasts (NHDFb) and HUVECs were cultured for 2 days in 8-well glass slides. Cells were then air-dried, fixed, and stained A–C) for CD90, D–F) for TE-7, G–I) for CD164, J–L) with HA-BP, and M–O) for cellular fibronectin. Cells were then counterstained with hematoxylin to identify nuclei. Bar is 50 µm.
Figure 7 Comparison of fibroblast markers on fibrocytes, fibroblasts, and HUVECs. PBMC were cultured as described in Figure 1. Normal human dermal fibroblasts (NHDFb) and HUVECs were cultured for 2 days in 8-well glass slides. Cells were then air-dried, fixed, and stained A–C) for CD90, D–F) for TE-7, G–I) for CD164, J–L) with HA-BP, and M–O) for cellular fibronectin. Cells were then counterstained with hematoxylin to identify nuclei. Bar is 50 µm.CC BY · PubMed Central
Figure 8 Expression of markers on macrophages cultured in serum and M-CSF. PBMC were cultured in SFM at 5×105 cells/ml in 8-well glass slides for 7 days in the presence of 10% FCS and 10 ng/ml M-CSF. Cells were then air-dried, fixed and stained with 5 µg/ml mouse IgG1 monoclonal antibodies against CD13, CD14, CD32, CD163, CD90, mouse IgG1, proyly-4-hydroxylase, 25F9, S100A8/A9, PM-2K, TE-7, and collagen-I. Cells were then counterstained with hematoxylin to identify nuclei. Inserts indicate staining at higher magnification. Bar is 50 µm.
Figure 8 Expression of markers on macrophages cultured in serum and M-CSF. PBMC were cultured in SFM at 5×105 cells/ml in 8-well glass slides for 7 days in the presence of 10% FCS and 10 ng/ml M-CSF. Cells were then air-dried, fixed and stained with 5 µg/ml mouse IgG1 monoclonal antibodies against CD13, CD14, CD32, CD163, CD90, mouse IgG1, proyly-4-hydroxylase, 25F9, S100A8/A9, PM-2K, TE-7, and collagen-I. Cells were then counterstained with hematoxylin to identify nuclei. Inserts indicate staining at higher magnification. Bar is 50 µm.CC BY · PubMed Central
Figure 9 Comparison of Fc receptors on PBMC ex-vivo and fibrocytes. PBMC were cultured in SFM at 5×105 cells/ml in 8-well glass slides for 1 hour (ex vivo) or 7 days. Cells were then air-dried, fixed, and stained with antibodies against A and B) CD64, C and D) CD32, E and F) CD16, G and H) CD32a, I and J) CD32b, or K and L) goat IgG control antibodies. Cells were then counterstained with hematoxylin to identify nuclei. Asterisks are to the right of macrophages. Bar is 50 µm.
Figure 9 Comparison of Fc receptors on PBMC ex-vivo and fibrocytes. PBMC were cultured in SFM at 5×105 cells/ml in 8-well glass slides for 1 hour (ex vivo) or 7 days. Cells were then air-dried, fixed, and stained with antibodies against A and B) CD64, C and D) CD32, E and F) CD16, G and H) CD32a, I and J) CD32b, or K and L) goat IgG control antibodies. Cells were then counterstained with hematoxylin to identify nuclei. Asterisks are to the right of macrophages. Bar is 50 µm.CC BY · PubMed Central
Figure 10 Comparison of collagen expression on fibrocytes and fibroblasts. PBMC were cultured as described in Figure 1. Normal human dermal fibroblasts were cultured for 2 days in 8-well glass slides. Cells were then air-dried, fixed, and stained with antibodies. A and B) collagen-I, C and D) collagen IV, E and F) proyly-4-hydroxylase, G and H) rabbit IgG control antibody. Cells were then counterstained with hematoxylin to identify nuclei. Asterisks are to the right of macrophages. Bar is 50 µm.
Figure 10 Comparison of collagen expression on fibrocytes and fibroblasts. PBMC were cultured as described in Figure 1. Normal human dermal fibroblasts were cultured for 2 days in 8-well glass slides. Cells were then air-dried, fixed, and stained with antibodies. A and B) collagen-I, C and D) collagen IV, E and F) proyly-4-hydroxylase, G and H) rabbit IgG control antibody. Cells were then counterstained with hematoxylin to identify nuclei. Asterisks are to the right of macrophages. Bar is 50 µm.CC BY · PubMed Central
Figure 11 Expression of markers on fibrocytes cultured for 21 days. PBMC were cultured in SFM at 5×105 cells/ml in 8-well glass slides for 21 days. Cells were then air-dried, fixed, and stained with antibodies. A) PM-2K, B) CD18, C) CD34, D) CD68, E) CD163, F) CD164, G) CD169, H) CD49c, and I) CD49e. Cells were then counterstained with hematoxylin to identify nuclei. Bar is 50 µm. Graph shows the percent positive CD49c (α3 integrin) expression over 21 days in culture. At least 100 elongated cells with oval nuclei were examined from at least 10 randomly selected fields, and the percentage of elongated cells that were positively stained by antibodies against the indicated markers is expressed as the mean±SEM (n = 5 separate donors). *** indicates p<0.001, as determined by ANOVA.
Figure 11 Expression of markers on fibrocytes cultured for 21 days. PBMC were cultured in SFM at 5×105 cells/ml in 8-well glass slides for 21 days. Cells were then air-dried, fixed, and stained with antibodies. A) PM-2K, B) CD18, C) CD34, D) CD68, E) CD163, F) CD164, G) CD169, H) CD49c, and I) CD49e. Cells were then counterstained with hematoxylin to identify nuclei. Bar is 50 µm. Graph shows the percent positive CD49c (α3 integrin) expression over 21 days in culture. At least 100 elongated cells with oval nuclei were examined from at least 10 randomly selected fields, and the percentage of elongated cells that were positively stained by antibodies against the indicated markers is expressed as the mean±SEM (n = 5 separate donors). *** indicates p<0.001, as determined by ANOVA.CC BY · PubMed Central
Figure 12 Comparison of markers on PBMC cultured for 1 day and day 7 fibrocytes. PBMC were cultured in SFM at 5×105 cells/ml in 8-well glass slides for 1 or 7 days. Cells were then air-dried, fixed, and stained with antibodies. A and B) Lamin B, C and D) galectin-3, E and F) CD49c, and G and H) CD49e. Cells were then counterstained with hematoxylin to identify nuclei. Asterisks indicate macrophages. Bar is 50 µm.
Figure 12 Comparison of markers on PBMC cultured for 1 day and day 7 fibrocytes. PBMC were cultured in SFM at 5×105 cells/ml in 8-well glass slides for 1 or 7 days. Cells were then air-dried, fixed, and stained with antibodies. A and B) Lamin B, C and D) galectin-3, E and F) CD49c, and G and H) CD49e. Cells were then counterstained with hematoxylin to identify nuclei. Asterisks indicate macrophages. Bar is 50 µm.CC BY · PubMed Central
Figure 13 Effect of cytokines on markers expressed by fibrocytes. PBMC were cultured in 8-well glass slides in SFM for 7 days, in the presence or absence of IL-4, or IFN-γ. Cells were then air-dried, fixed, and stained with antibodies. A–C) CD13, D–F) CD163, G–I) CD172a, J–L) CD206, and M–O) CD209. Cells were counterstained with hematoxylin to identify nuclei. Bar is 50 µm.
Figure 13 Effect of cytokines on markers expressed by fibrocytes. PBMC were cultured in 8-well glass slides in SFM for 7 days, in the presence or absence of IL-4, or IFN-γ. Cells were then air-dried, fixed, and stained with antibodies. A–C) CD13, D–F) CD163, G–I) CD172a, J–L) CD206, and M–O) CD209. Cells were counterstained with hematoxylin to identify nuclei. Bar is 50 µm.CC BY · PubMed Central
Figure 14 Effect of SAP on markers expressed by macrophages. PBMC were cultured in 8-well glass slides in SFM for 7 days, in the presence or absence of SAP. Cells were then air-dried, fixed, and stained with antibodies. A–B) CD14, C–D) CD32a, E–F) CD32b, G–H) CD68, I–J) CD163, and K–L) CD172a. Cells were counterstained with hematoxylin to identify nuclei. Bar is 50 µm.
Figure 14 Effect of SAP on markers expressed by macrophages. PBMC were cultured in 8-well glass slides in SFM for 7 days, in the presence or absence of SAP. Cells were then air-dried, fixed, and stained with antibodies. A–B) CD14, C–D) CD32a, E–F) CD32b, G–H) CD68, I–J) CD163, and K–L) CD172a. Cells were counterstained with hematoxylin to identify nuclei. Bar is 50 µm.CC BY · PubMed Central
Figure 15 Identification of fibrocytes in pathological samples. “HOPE-fixed” human lung tissue sections were stained with antibodies against CD32, CD45RO, CD68, CD164, collagen-I, PM-2K, and TE-7. Sections were stained for A) CD45RO (green), CD68 (red) and DAPI (blue). An example of a CD45RO positive lymphocyte is indicated with a solid arrow. Dual labeled CD45RO and CD68 macrophages and fibrocytes are indicated by open arrows. B) CD45RO (green), PM-2K (red) and DAPI (blue). An example of a dual labeled CD45RO and PM-2K tissue macrophage is indicated with a solid arrow. C) CD45RO (green), collagen-I (red), and DAPI (blue). Dual labeled CD45RO and collagen-I positive cells are yellow. D) PM-2K (green), collagen-I (red), and DAPI (blue). A cluster of PM-2K positive alveolar macrophages is indicated with an open arrow. E) CD45RO (green), CD164 (red), and DAPI (blue). An area of CD164 positive fibroblasts is indicated with a solid arrow. A dual labeled CD45RO and CD164 positive fibrocyte is indicated by an open arrow. F) CD45RO (green), collagen-I (red), and TE-7 (blue). Dual positive TE-7/collagen-I fibroblasts are magenta. G) TE-7 (green), CD32 (red), and DAPI (blue). An example of CD32 positive fibrocytes is indicated with an open arrow. H) Nuclei (white), PM-2K (green), collagen (red), and CD32 (blue). A cluster of PM-2K positive alveolar macrophages are indicated with an asterisk. An area of CD32 and collagen positive/PM-2K negative fibrocytes is indicated with an open arrow. An area of collagen positive/CD32 negative fibroblasts is indicated with a solid arrow. Cells were counterstained with DAPI to identify nuclei. Bars are 100 µm.
Figure 15 Identification of fibrocytes in pathological samples. “HOPE-fixed” human lung tissue sections were stained with antibodies against CD32, CD45RO, CD68, CD164, collagen-I, PM-2K, and TE-7. Sections were stained for A) CD45RO (green), CD68 (red) and DAPI (blue). An example of a CD45RO positive lymphocyte is indicated with a solid arrow. Dual labeled CD45RO and CD68 macrophages and fibrocytes are indicated by open arrows. B) CD45RO (green), PM-2K (red) and DAPI (blue). An example of a dual labeled CD45RO and PM-2K tissue macrophage is indicated with a solid arrow. C) CD45RO (green), collagen-I (red), and DAPI (blue). Dual labeled CD45RO and collagen-I positive cells are yellow. D) PM-2K (green), collagen-I (red), and DAPI (blue). A cluster of PM-2K positive alveolar macrophages is indicated with an open arrow. E) CD45RO (green), CD164 (red), and DAPI (blue). An area of CD164 positive fibroblasts is indicated with a solid arrow. A dual labeled CD45RO and CD164 positive fibrocyte is indicated by an open arrow. F) CD45RO (green), collagen-I (red), and TE-7 (blue). Dual positive TE-7/collagen-I fibroblasts are magenta. G) TE-7 (green), CD32 (red), and DAPI (blue). An example of CD32 positive fibrocytes is indicated with an open arrow. H) Nuclei (white), PM-2K (green), collagen (red), and CD32 (blue). A cluster of PM-2K positive alveolar macrophages are indicated with an asterisk. An area of CD32 and collagen positive/PM-2K negative fibrocytes is indicated with an open arrow. An area of collagen positive/CD32 negative fibroblasts is indicated with a solid arrow. Cells were counterstained with DAPI to identify nuclei. Bars are 100 µm.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 79

  1. P Martin, 1997, Wound Healing—Aiming for Perfect Skin Regeneration., Science, 276, 75, 10.1126/science.276.5309.75 · DOI
  2. MF Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells., Science, 284, 143, 10.1126/science.284.5411.143 · DOI · Paper page
  3. DG Phinney, 2007, Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair—current views., Stem Cells, 25, 2896, 10.1634/stemcells.2007-0637 · DOI
  4. R Kalluri, 2003, Epithelial-mesenchymal transition and its implications for fibrosis., Journal Of Clinical Investigation, 112, 1776, 10.1172/JCI200320530 · DOI
  5. R Bucala, 1994, Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair., Molecular Medicine, 1, 71, 10.1007/BF03403533 · DOI
  6. BN Gomperts, 2007, Fibrocytes in lung disease., Journal Of Leukocyte Biology, 82, 449, 10.1189/jlb.0906587 · DOI
  7. A Bellini, 2007, The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses., Lab Invest, 87, 858, 10.1038/labinvest.3700654 · DOI
  8. JF Wang, 2007, Fibrocytes from burn patients regulate the activities of fibroblasts., Wound Repair Regen, 15, 113, 10.1111/j.1524-475X.2006.00192.x · DOI
  9. SB Haudek, 2006, Bone Marrow-derived Fibroblast Precursors Mediate Ischemic Cardiomyopathy in Mice., Proceedings of the National Academy of Sciences, 103, 18284, 10.1073/pnas.0608799103 · DOI
  10. B Naik-Mathuria, 2008, Serum amyloid P inhibits dermal wound healing., Wound Repair and Regeneration, 16, 266, 10.1111/j.1524-475X.2008.00366.x · DOI
  11. L Yang, 2002, Peripheral Blood Fibrocytes from Burn Patients: Identification and Quantification of Fibrocytes in Adherent Cells Cultured from Peripheral Blood Mononuclear Cells., Laboratory Investigation, 82, 1183, 10.1097/01.LAB.0000027841.50269.61 · DOI
  12. D Pilling, 2003, Inhibition of fibrocyte differentiation by serum amyloid P., Journal Of Immunology, 17, 5537, 10.4049/jimmunol.171.10.5537 · DOI
  13. D Pilling, 2006, Aggregated IgG inhibits the differentiation of human fibrocytes., Journal Of Leukocyte Biology, 79, 1242, 10.1189/jlb.0805456 · DOI
  14. DD Shao, 2008, Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation., Journal of Leukocyte Biology, 83, 1323, 10.1189/jlb.1107782 · DOI
  15. J Wang, 2007, Accelerated wound healing in leukocyte-specific, protein 1-deficient mouse is associated with increased infiltration of leukocytes and fibrocytes., J Leukoc Biol, 82, 1554, 10.1189/jlb.0507306 · DOI
  16. RJ Phillips, 2004, Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis., J Clin.Invest, 114, 438, 10.1172/JCI200420997 · DOI
  17. N Hashimoto, 2004, Bone marrow-derived progenitor cells in pulmonary fibrosis., Journal Of Clinical Investigation, 113, 243, 10.1172/JCI200418847 · DOI
  18. BB Moore, 2005, CCR2-Mediated Recruitment of Fibrocytes to the Alveolar Space after Fibrotic Injury., American Journal Of Pathology, 166, 675, 10.1016/S0002-9440(10)62289-4 · DOI
  19. BB Moore, 2006, The Role of CCL12 in the Recruitment of Fibrocytes and Lung Fibrosis., American Journal Of Respiratory Cell And Molecular Biology, 35, 175, 10.1165/rcmb.2005-0239OC · DOI
  20. A Andersson-Sjöland, 2008, Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis., The International Journal of Biochemistry & Cell Biology, 40, 2129, 10.1016/j.biocel.2008.02.012 · DOI
  21. L Yang, 2005, Identification of fibrocytes in postburn hypertrophic scar., Wound Repair and Regeneration, 13, 398, 10.1111/j.1067-1927.2005.130407.x · DOI
  22. M Salmon, 1994, The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis., European Journal Of Immunology, 24, 892, 10.1002/eji.1830240417 · DOI
  23. CD Buckley, 2000, Persistent induction of the chemokine receptor CXCR4 by TGF-beta1 on synovial T cells contributes to their accumulation within the rheumatoid synovium., J.Immunol, 165, 3423, 10.4049/jimmunol.165.6.3423 · DOI
  24. R García-Vicuña, 2004, CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients., Arthritis & Rheumatism, 50, 3866, 10.1002/art.20615 · DOI
  25. H Zhao, 2009, Tumor-promoting phenotype of CD90(hi) prostate cancer-associated fibroblasts., Prostate, 69, 991, 10.1002/pros.20946 · DOI
  26. Y Hosokawa, 2005, CXCL12 and CXCR4 expression by human gingival fibroblasts in periodontal disease., Clin Exp Immunol, 141, 467, 10.1111/j.1365-2249.2005.02852.x · DOI
  27. QH Erdag G, 2008, CD34-positive dendritic cells disappear from scars but are increased in pericicatricial tissue., Journal of Cutaneous Pathology, 35, 752, 10.1111/j.1600-0560.2007.00895.x · DOI
  28. BJ Nickoloff, 1991, The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma., Arch Dermatol, 127, 523, 10.1001/archderm.1991.04510010091009 · DOI
  29. DL Simmons, 1992, Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells., Journal Of Immunology, 148, 267, 10.4049/jimmunol.148.1.267 · DOI
  30. J Vaage, 1990, Production of collagen type I by mouse peritoneal macrophages., J Leukoc Biol, 48, 274, 10.1002/jlb.48.3.274 · DOI
  31. MJ Liptay, 1993, Neointimal macrophages colocalize with extracellular matrix gene expression in human atherosclerotic pulmonary arteries., J Clin Invest, 91, 588, 10.1172/JCI116238 · DOI
  32. A Gratchev, 2001, Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3., Scand J Immunol, 53, 386, 10.1046/j.1365-3083.2001.00885.x · DOI · Paper page
  33. JS Duffield, 2003, The inflammatory macrophage: a story of Jekyll and Hyde., Clin Sci (Lond), 104, 27, 10.1042/cs1040027 · DOI
  34. M Schnoor, 2008, Production of Type VI Collagen by Human Macrophages: A New Dimension in Macrophage Functional Heterogeneity., J Immunol, 180, 5707, 10.4049/jimmunol.180.8.5707 · DOI
  35. M Lucattelli, 2003, Collagen phagocytosis by lung alveolar macrophages in animal models of emphysema., Eur Respir J, 22, 728, 10.1183/09031936.03.00047603 · DOI
  36. RP Phipps, 1989, Characterization of two major populations of lung fibroblasts: distinguishing morphology and discordant display of Thy 1 and class II MHC., Am J Respir Cell Mol Biol, 1, 65, 10.1165/ajrcmb/1.1.65 · DOI
  37. HY Chang, 2002, Diversity, topographic differentiation, and positional memory in human fibroblasts., Proc Natl Acad Sci U S A, 99, 12877, 10.1073/pnas.162488599 · DOI
  38. CD Buckley, 2001, Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation., Trends Immunol, 22, 199, 10.1016/S1471-4906(01)01863-4 · DOI · Paper page
  39. G Parsonage, 2003, Global gene expression profiles in fibroblasts from synovial, skin and lymphoid tissue reveals distinct cytokine and chemokine expression patterns., Thromb.Haemost, 90, 688, 10.1160/TH03-04-0208 · DOI
  40. S Halder, 2005, Generation and characterization of novel stromal specific antibodies., Cell Res, 15, 739, 10.1038/sj.cr.7290344 · DOI
  41. JR MacFadyen, 2005, Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium., FEBS Lett, 579, 2569, 10.1016/j.febslet.2005.03.071 · DOI
  42. S Lax, 2007, CD248/Endosialin is dynamically expressed on a subset of stromal cells during lymphoid tissue development, splenic remodeling and repair., FEBS Lett, 581, 3550, 10.1016/j.febslet.2007.06.063 · DOI
  43. CJ Cabezon T, 2007, Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer., International Journal of Cancer, 121, 1433, 10.1002/ijc.22850 · DOI
  44. SD Ko, 1977, Fibroblast heterogeneity and prostaglandin regulation of subpopulations., Proc Natl Acad Sci U S A, 74, 3429, 10.1073/pnas.74.8.3429 · DOI
  45. L Peduto, 2009, Inflammation Recapitulates the Ontogeny of Lymphoid Stromal Cells., J Immunol, 182, 5789, 10.4049/jimmunol.0803974 · DOI
  46. F Strutz, 1995, Identification and characterization of a fibroblast marker: FSP1., J Cell Biol, 130, 393, 10.1083/jcb.130.2.393 · DOI
  47. JE Fonseca, 2002, Macrophage subpopulations in rheumatoid synovium: reduced CD163 expression in CD4+ T lymphocyte-rich microenvironments., Arthritis And Rheumatism, 46, 1210, 10.1002/art.10207 · DOI
  48. E Kunisch, 2004, Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry., Ann Rheum Dis, 63, 774, 10.1136/ard.2003.013029 · DOI
  49. T Inoue, 2005, Antibodies against macrophages that overlap in specificity with fibroblasts., Kidney Int, 67, 2488, 10.1111/j.1523-1755.2005.00358.x · DOI
  50. E Gottfried, 2008, Expression of CD68 in non-myeloid cell types., Scand J Immunol, 67, 453, 10.1111/j.1365-3083.2008.02091.x · DOI
  51. S Becker, 1987, Colony-stimulating factor-induced monocyte survival and differentiation into macrophages in serum-free cultures., J Immunol, 139, 3703, 10.4049/jimmunol.139.11.3703 · DOI
  52. W Brugger, 1991, Macrophage colony-stimulating factor is required for human monocyte survival and acts as a cofactor for their terminal differentiation to macrophages in vitro., J Leukoc Biol, 49, 483, 10.1002/jlb.49.5.483 · DOI
  53. DA Hume, 2002, The mononuclear phagocyte system revisited., Journal Of Leukocyte Biology, 72, 621, 10.1189/jlb.72.4.621 · DOI
  54. KJ Way, 2009, The generation and properties of human macrophage populations from hemopoietic stem cells., J Leukoc Biol, 85, 766, 10.1189/jlb.1108689 · DOI
  55. M Salmon, 1997, Inhibition of T cell apoptosis in the rheumatoid synovium., Journal Of Clinical Investigation, 99, 439, 10.1172/JCI119178 · DOI
  56. D Pilling, 1999, Interferon-β mediates stromal cell rescue of T cells from apoptosis., European Journal Of Immunology, 29, 1041, 10.1002/(SICI)1521-4141(199903)29:03<1041::AID-IMMU1041>3.0.CO;2-# · DOI
  57. J Olert, 2001, HOPE fixation: a novel fixing method and paraffin-embedding technique for human soft tissues., Pathol Res Pract, 197, 823, 10.1078/0344-0338-00166 · DOI
  58. AN Akbar, 1996, Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal - selective induction of anti-apoptotic (Bcl-2, Bcl-xL) but not pro-apoptotic (Bax, Bcl-xS) gene-expression., European Journal Of Immunology, 26, 294, 10.1002/eji.1830260204 · DOI
  59. JM Faint, 1999, Quantitative flow cytometry for the analysis of T cell receptor Valpha chain expression., Journal Of Immunological Methods, 27, 53, 10.1016/S0022-1759(99)00027-7 · DOI
  60. LW Terstappen, 1990, Quantitative comparison of myeloid antigens on five lineages of mature peripheral blood cells., J Leukoc Biol, 48, 138, 10.1002/jlb.48.2.138 · DOI
  61. S Rosseau, 2000, Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome., Am J Physiol Lung Cell Mol Physiol, 279, L25, 10.1152/ajplung.2000.279.1.L25 · DOI
  62. DJ Flavell, 1987, Identification of tissue histiocytes on paraffin sections by a new monoclonal antibody., J Histochem Cytochem, 35, 1217, 10.1177/35.11.3309045 · DOI
  63. G Zwadlo, 1985, A monoclonal antibody to a differentiation antigen present on mature human macrophages and absent from monocytes., J Immunol, 134, 1487, 10.4049/jimmunol.134.3.1487 · DOI
  64. M Takeya, 1991, A new monoclonal antibody, PM-2K, specifically recognizes tissue macrophages but not blood monocytes., The Journal of pathology, 163, 315, 10.1002/path.1711630408 · DOI
  65. SS Bohlson, 2005, CD93 is rapidly shed from the surface of human myeloid cells and the soluble form is detected in human plasma., J Immunol, 175, 1239, 10.4049/jimmunol.175.2.1239 · DOI
  66. E Grage-Griebenow, 2001, Heterogeneity of human peripheral blood monocyte subsets., J.Leukoc.Biol, 69, 11, 10.1189/jlb.69.1.11 · DOI
  67. J Faust, 1999, Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors., J Cell Biochem, 72, 67, 10.1002/(SICI)1097-4644(19990101)72:1<67::AID-JCB8>3.0.CO;2-A · DOI
  68. SB Haudek, 2008, Fc Receptor Engagement Mediates Differentiation of Cardiac Fibroblast Precursor Cells., Proceedings of the National Academy of Sciences, 105, 10179, 10.1073/pnas.0804910105 · DOI
  69. B Passlick, 1989, Identification and characterization of a novel monocyte subpopulation in human peripheral blood., Blood, 74, 2527, 10.1182/blood.V74.7.2527.2527 · DOI
  70. M Schmidt, 2003, Identification of Circulating Fibrocytes as Precursors of Bronchial Myofibroblasts in Asthma., The Journal of Immunology, 171, 380, 10.4049/jimmunol.171.1.380 · DOI
  71. 2007, Leukocyte and Stromal Cell Molecules: The CD Markers: John Wiley & Sons.
  72. G Balciunaite, 2005, A B220+ CD117+ CD19- hematopoietic progenitor with potent lymphoid and myeloid developmental potential., Eur J Immunol, 35, 2019, 10.1002/eji.200526318 · DOI
  73. Y Su, 2005, Glycosylation Influences the Lectin Activities of the Macrophage Mannose Receptor., J Biol Chem, 280, 32811, 10.1074/jbc.M503457200 · DOI
  74. NC Henderson, 2008, Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis., Am J Pathol, 172, 288, 10.2353/ajpath.2008.070726 · DOI · Paper page
  75. GS Firestein, 1987, Down regulation of human monocyte differentiation antigens by interferon gamma., Cell Immunol, 104, 343, 10.1016/0008-8749(87)90036-0 · DOI
  76. AL Epstein, 1987, Immunohistochemical characterization of a 183 KD myeloid-specific-DNA-binding protein in B5 fixed, paraffin-embedded tissues, and bone marrow aspirates by monoclonal antibody BM-1., Blood, 70, 1124, 10.1182/blood.V70.4.1124.1124 · DOI
  77. FO Martinez, 2008, Macrophage activation and polarization., Front Biosci, 13, 453, 10.2741/2692 · DOI · Paper page
  78. L Zeng, 1996, Interspecies reactivities of anti-human macrophage monoclonal antibodies to various animal species., J Histochem Cytochem, 44, 845, 10.1177/44.8.8756757 · DOI
  79. O Dewald, 2004, Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction., Am J Pathol, 164, 665, 10.1016/S0002-9440(10)63154-9 · DOI

Cited by

Metadata

Authors
Pilling, D., Fan, T., Huang, D., Kaul, B., & Gomer, R. H.
Venue
PLoS ONE
Publisher
Public Library of Science (PLoS)
Published
2009-10-16
Volume
4
Issue
10
Pages
e7475
ISSN
1932-6203
DOI
10.1371/journal.pone.0007475
PMC
PMC2759556
Cited by
433
References
7
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review